Related Experiment Video
Updated: Jun 4, 2026
08:45
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Role of Pten in leukemia stem cells
Cong Peng1, Yaoyu Chen1, Dongguang Li2
1Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.
Oncotarget
|February 8, 2011
Summary
The tumor suppressor gene Pten is downregulated in leukemia stem cells (LSCs) in chronic myeloid leukemia (CML). Enhancing the Pten pathway offers a new therapeutic strategy for targeting CML LSCs.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Chronic myeloid leukemia (CML) originates from leukemia stem cells (LSCs) that are resistant to current therapies.
- Existing treatments like imatinib, dasatinib, and nilotinib fail to eradicate CML LSCs.
- Identifying novel therapeutic targets for CML LSC eradication is crucial.
Purpose of the Study:
- To investigate the role of the tumor suppressor gene Pten in the survival and proliferation of CML LSCs.
- To explore the potential of Pten pathway modulation as a therapeutic strategy against CML.
Main Methods:
- Analysis of Pten gene expression in CML mouse models.
- Genetic manipulation (deletion and overexpression) of Pten in LSCs.
- Assessment of Pten's functional role in LSC biology.
Main Results:
- Pten was found to be downregulated in CML LSCs.
- Pten acts as a tumor suppressor in CML LSCs.
- Pten's tumor-suppressive function in CML LSCs is consistent with its role in other leukemia models.
Conclusions:
- The Pten pathway is a critical regulator of CML LSC survival and proliferation.
- Therapeutic strategies aimed at enhancing Pten signaling could be effective for targeting CML LSCs.
- Targeting Pten offers a promising approach for eradicating resistant leukemia stem cells in CML.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...